- Home
- HCAT
HCAT
Health Catalyst Inc
as 09-06-2024 4:00pm EST
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SOUTH JORDAN |
| Market Cap: | 378.4M | IPO Year: | 2019 |
| Target Price: | $11.73 | AVG Volume (30 days): | 458.0K |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.42 - $11.98 | Next Earning Date: | 10-31-2024 |
| Revenue: | $299,482,000 | Revenue Growth: | 5.23% |
| Revenue Growth (this year): | 5.98% | Revenue Growth (next year): | 11.52% |
Stock Insider Trading Activity of Health Catalyst Inc (HCAT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LeSueur Daniel | HCAT | Chief Operating Officer | Sep 3 '24 | Sell | $7.58 | 8,137 | $61,718.33 | 140,108 | |
| Llewelyn Linda | HCAT | Chief People Officer | Jul 15 '24 | Sell | $6.51 | 1,290 | $8,397.90 | 119,864 | |
| LeSueur Daniel | HCAT | Chief Operating Officer | Jul 3 '24 | Sell | $6.15 | 5,208 | $32,048.99 | 140,108 | |
| Llewelyn Linda | HCAT | Chief People Officer | Jun 17 '24 | Sell | $6.37 | 1,290 | $8,220.53 | 119,864 | |
| Alger Jason | HCAT | Chief Financial Officer | Jun 12 '24 | Sell | $6.83 | 2,823 | $19,281.09 | 118,170 | |
| Freeman Kevin Lee | HCAT | Chief Commercial Officer | Jun 11 '24 | Sell | $6.53 | 7,500 | $49,008.00 | 266,153 |
Latest Health Catalyst Inc News
HCAT Breaking Stock News: Dive into HCAT Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
Health Catalyst to Participate in Upcoming Investor Conferences
PR Newswire
13 days ago
WISHIN Expands Relationship with Health Catalyst, Signing Multi-Year Partnership to Migrate to Ninja Universe™ Suite
Simply Wall St.
a month ago
Health Catalyst Second Quarter 2024 Earnings: Beats Expectations
Hospital Management
a month ago
Health Catalyst acquires digital health company Lumeon
StockStory
a month ago
Why Health Catalyst (HCAT) Stock Is Up Today
PR Newswire
a month ago
Health Catalyst Announces Partnership Expansion with Western U.S.'s Largest Health Information Exchange, Contexture
PR Newswire
a month ago
Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon
PR Newswire
a month ago
Health Catalyst and South Dakota Health Link Expand Partnership to Improve the Quality and Effectiveness of Healthcare in the Midwest
Compare HCAT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HCAT Health Catalyst Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.